Phillip G. Febbo - Mar 6, 2024 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Role
Chief Scientific & Med Officer
Signature
/s/ Jonathan Wygant, as attorney-in-fact
Stock symbol
VCYT
Transactions as of
Mar 6, 2024
Transactions value $
$0
Form type
4
Date filed
3/8/2024, 04:36 PM
Previous filing
Oct 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCYT Common Stock Award $0 +39.9K +75.03% $0.00 93.1K Mar 6, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units awarded on March 6, 2024 vest 25% on March 2, 2025 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.